Virus inactivation in the 1990s - and into the 21st century. Part 3b, plasma and plasma products (treatments other than heat or solvent/detergent)

The latest installment of our series on recently published methods for inactivating viruses reviews the literature on virus inactivation in plasma and plasma products by chemical treatments, gamma and UV irradiation, and low-pH treatment.

[1]  J. Huraux,et al.  Photodynamic inactivation of cell-free HIV strains by a red-absorbing chlorin-type photosensitizer. , 1995, Journal of photochemistry and photobiology. B, Biology.

[2]  C. Prowse,et al.  A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco‐Tronic system , 2001, Transfusion medicine.

[3]  R. Volk,et al.  Inactivation of HIV-1 and HIV-2 by various manufacturing procedures for human plasma proteins. , 1990, Cancer detection and prevention.

[4]  B. Lambrecht,et al.  Photoinactivation of Viruses in Human Fresh Plasma by Phenothiazine Dyes in Combination with Visible Light , 1991, Vox sanguinis.

[5]  M. Tersmette,et al.  Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors , 1991, Transfusion.

[6]  H. Mohr,et al.  Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma , 1998, Journal of medical virology.

[7]  C. Kempf,et al.  Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation , 1996, Transfusion.

[8]  H. Dichtelmüller,et al.  Validation of virus inactivation and removal for the manufacturing procedure of two immunoglobulins and a 5% serum protein solution treated with beta-propiolactone. , 1993, Biologicals : journal of the International Association of Biological Standardization.

[9]  K. Reid,et al.  Inactivation of Viruses during Ultraviolet Light Treatment of Human Intravenous Immunoglobulin and Albumin , 1993, Vox sanguinis.

[10]  H. Sies,et al.  Inactivation of viruses by chemically and photochemically generated singlet molecular oxygen. , 1995, Journal of photochemistry and photobiology. B, Biology.

[11]  P. Gottlieb,et al.  Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants. , 1995, Blood.

[12]  E. Ben-hur,et al.  ADVANCES IN PHOTOCHEMICAL APPROACHES FOR BLOOD STERILIZATION , 1995, Photochemistry and photobiology.

[13]  M. Yamaguchi,et al.  Inactivation of parvovirus B19 in coagulation factor concentrates by UVC radiation: assessment by an in vitro infectivity assay using CFU–E derived from peripheral blood CD34+ cells , 2001, Transfusion.

[14]  D. Bradley,et al.  Pressure cycling technology:a novel approach to virus inactivation in plasma , 2000, Transfusion.

[15]  L. Benade,et al.  Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate. , 1995, Blood.

[16]  U. Klockmann,et al.  Virus safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure , 1992, Journal of medical virology.

[17]  H. Mohr.  Inactivation of viruses in human plasma. , 2000, Methods in enzymology.

[18]  B. Bachmann,et al.  Target structures for HIV‐1 inactivation by methylene blue and light , 1995, Journal of medical virology.

[19]  G. Mitra,et al.  Inactivation of hepatitis C virus in low pH intravenous immunoglobulin. , 1994, Biologicals : journal of the International Association of Biological Standardization.

[20]  R. Kurth,et al.  Rapid inactivation of HIV-1 in single donor preparations of human fresh frozen plasma by methylene blue/light treatment. , 1994, Biologicals : journal of the International Association of Biological Standardization.

[21]  C. Kessler,et al.  New methods for inactivation of lipid‐enveloped and nonenveloped viruses , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[22]  W. Drohan,et al.  Viral inactivation of vesicular stomatitis virus in normal human serum by cross-linked polyvinylpyrrolidone. , 1993, The Journal of infectious diseases.

[23]  C. Kempf,et al.  Virus inactivation during production of intravenous immunoglobulin , 1991, Transfusion.

[24]  P. Ukkonen,et al.  Virus Inactivation during Intravenous Immunoglobulin Production , 1992, Vox sanguinis.

[25]  G. Pauli,et al.  Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates. , 1998, Biologicals (Print).

[26]  B. Lambrecht,et al.  Photo-inactivation of viruses in therapeutical plasma. , 1993, Developments in biological standardization.

[27]  G. Sofer.  Virus Inactivation in the 1990s — and into the 21st Century Part 3a, Plasma and Plasma Products (Heat and Solvent/Detergent Treatments) , 2002 .

[28]  M. Korneyeva,et al.  Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates. , 2002, Biologicals : journal of the International Association of Biological Standardization.

[29]  H. Abe,et al.  Elimination of both cell‐free and cell‐associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system , 2000, Transfusion.

[30]  G. Wiesehahn,et al.  Photochemical inactivation of viruses and bacteriophage in plasma and plasma fractions. , 1992, Blood cells.

[31]  Foster Pr,et al.  Current safety of clotting factor concentrates. , 1990 .

[32]  S. Lawrence.  beta-Propiolactone: viral inactivation in vaccines and plasma products. , 2000, PDA journal of pharmaceutical science and technology.

[33]  J. Lundblad,et al.  Inactivation of Lipid‐Enveloped Viruses in Proteins by Caprylate , 1991, Vox sanguinis.

[34]  E. Ben-hur,et al.  Protecting Fibrinogen with Rutin during UVC Irradiation for Viral Inactivation , 1996, Photochemistry and photobiology.

[35]  C. Kempf,et al.  Inactivation of human immunodeficiency virus (HIV) by low pH and pepsin. , 1991, Journal of acquired immune deficiency syndromes.

[36]  W. Drohan,et al.  Inactivation of lipid‐enveloped and non‐lipid‐enveloped model viruses in normal human plasma by crosslinked starch‐iodine , 1994, Transfusion.

[37]  B. Lambrecht,et al.  Photodynamic virus inactivation of blood components. , 1995, Immunological investigations.